Board of Directors

Michael R. Sonnenreich - Chairman of the Board

Mr. Sonnenreich is a lawyer and a philanthropist and has extensive management experiences in various industries; Technology, Pharmaceutical and Global Marketing. He is an active stake holder and advisor to several national and international companies. Currently, Mr. Sonnenreich is the Chairman of the Board of Kikaku America International, President of The Fund to Conserve United States Diplomatic Treasures Abroad (The Fund to Conserve) and Vice Chairman of PharMa International Corporation of Tokyo, Japan. He is a graduate of the University of Wisconsin, the University of Madrid, Spain, and Harvard University Law School. In the past twelve years Mr. Sonnenreich has served as a board member and trustee of numerous important companies and universities, including Williams Creek Explorations, Vancouver, British Columbia, Canada; Wi2Wi, San Jose, California; Tyhee Development Corp. Ltd., Vancouver, British Columbia, Canada; Les Aliments SoYummi, Inc., Montreal, Canada; the ABD American Capital Market Funds; the Integra Fund; Continental Steel Inc.; Amorfix Life Sciences Ltd. (now Promis Neurosciences), Vancouver, British Columbia, Canada; Scientific American; and Medical Tribune International.

Mr. Sonnenreich has had long-term involvement with many nonprofit institutions. These include the Washington National Opera (President 1996-98; 2002-2006); D.C. Jazz Festival (Chairman, 2010-2014); Sackler/Freer Galleries of Art (Smithsonian Institution), D.C.; Commission on the Arts and Humanities (Mayoral Appointment as Commissioner, 2008-2011); the Johns Hopkins University School of Advanced International Studies; the New England Conservatory of Music; the North Carolina Museum of Art Foundation; the University of Virginia Art Museum; Clark University; the Maret School; and the Richard Tucker Music Foundation. Mr. Sonnenreich served as President of the National Coordinating Council on Drug Education. In 2008, he was named Distinguished Washingtonian by the University Club of Washington, D.C. He previously served in government in the Department of Justice and was appointed Executive Director of the National Commission on Marijuana and Drug Abuse.

Fraser C. Henderson Sr. - M.D

Dr. Henderson is a world renowned Board-certified Neurological Surgeon and a retired US Navy Commander. He has received both his bachelor’s and Medical degree from the University of Virginia, Charlottesville Virginia. He completed his fellowship in Craniospinal surgery under Professor Alan Crockard at The National Hospital for Neurology and Neurosurgery, Queen Square, London. As Part of his active duty obligations; Dr. Henderson was the Director of Spine at National Naval Medical Center, Bethesda, MD and was Brigade Neurosurgeon for the 4th Marine Expeditionary Brigade in Desert Shield and Desert Storm during the 1st Gulf War. Finishing his tour with the US Navy, Commander Henderson joined Georgetown University, in Washington D.C. as Director of Neurosurgery of the Spine and Cranio-cervical Junction. He was Co-Director of the Lombardi Neuro-Oncology Division, Co-Director of the CyberKnife Radiosurgery Center, and Medical Director of the Neuroscience Nursing Units. He was Professor of Neurosurgery and Radiology at Georgetown University, where he was active in advancing CyberKnife radiosurgery for treatment of chordoma and other complex spinal tumors. He is the Director of Neurosurgery at Doctors Hospital and Director of the Chiari Center of Excellence, where he is focused on the development of the understanding and treatment of deformity induced injury to the brainstem and spinal cord in Chiari Malformation and Ehlers Danlos Syndrome.

Dr. Henderson developed intellectual property for three inventions relating to spinal radiosurgery and spinal cancer, including the TPS® –Telescopic Plate Spacer- a vertebral replacement device for metastatic disease and was Principal Investigator in the translational development of a radio-sensitizing drug, and a drug to block the malignant invasiveness of Glioblastoma Multiforme. He is an inventor of 11 devices and concepts relating to disorders of the brainstem and spinal cord, and has published over 50 peer reviewed articles and book chapters, and given over 120 invited lectures with a focus on craniocervical disorders, Chiari malformation, cancer, radiosurgery and unusual problems of the spine.

Harry J.F. Bloomfield - Q.C.

Mr. Bloomfield is principal and managing partner of the law firm Bloomfield & Avocats. He specializes in Canadian corporate law, international finance, securities law and international taxation law. Mr. Bloomfield also has experience in international banking law, shipping law, and patent and trademark law, finance and mergers and acquisitions. He is Chairman of the Humane Society of Canada and sits on the boards of numerous private and public entities including the Jewish National Fund of Canada. Mr. Bloomfield obtained his law degree from the University de Montreal and a Masters of Business Administration from the Harvard Graduate School of Business Administration. Mr. Bloomfield has been a director of Wi2Wi since December 2008.

Michael Pesner - CPA, CA

Michael Pesner has been President of Hermitage Canada Finance Inc. since 2002, a firm specializing in financial advisory services. He was previously a senior partner in financial advisory services at KPMG LLP, Chartered Accountants, in Montreal, specializing in corporate finance, mergers and acquisitions, divestitures, restructuring and corporate recovery in Canada. Mr. Pesner holds a Bachelor of Commerce degree in Finance and Administration from McGill University as well as a Bachelor of Arts degree from Sir George Williams University. Mr. Pesner is also a Chartered Accountant, a licensed Trustee in Bankruptcy and a Certified Insolvency and Restructuring Professional. Mr. Pesner is a director of Richmont Mines Inc., a company listed on the TSX and NYSEamex, Quest Rare Minerals Ltd; a Canadian exploration and development company, Mint Technology Corp, a company listed on the TSXV, Sand Technology Inc., a company listed on the OTCBB, and Bitumen Capital Inc., a capital pool company listed on the NEX.

Pierre Soulard - Company Secretary

Pierre Soulard has a corporate law practice that focuses on securities as well as corporate finance, mergers and acquisitions, and general corporate matters. Pierre has particular industry expertise in the areas of technology and life sciences. His practice focuses on corporate finance and public and private mergers and acquisitions, as well as private equity transactions and corporate governance. Mr. Soulard received a Master of Laws from Osgoode Hall Law School and both a Bachelor of Civil Laws and a Bachelor of Laws from McGill University. Mr. Soulard is a member of the Ontario Securities Commission Small and Medium Enterprises Committee.

Currently, Mr. Soulard is a partner in the Toronto office of Miller Thomson and formerly, he was a partner in the Toronto office of Norton Rose Fulbright Canada LLP.

Acting for fast-growing national and global companies, Pierre’s experience includes guidance on public offerings, private placements, takeover bids, mergers and acquisitions, and corporate governance. He advises senior executives and boards of directors at public and private corporations, independent board committees, financial advisers, and private equity funds in connection with acquisitions, divestitures, proxy contests, and restructurings. Pierre also advises issuers and underwriters in securities offerings in the domestic and international capital markets.

Zachariah J. Mathews - President and Chief Executive Officer

Mr. Mathews was previously the Chief Operating Officer of Wi2Wi. He has over 18 years of management experience in Semiconductor Operations, manufacturing and business development. He has held management positions in various roles at Micro linear Corporation, Sirenza Micro devices and RF Micro devices. Mr. Mathews has undergraduate and graduate degrees in business and Management accounting.